Literature DB >> 1911707

Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation.

H F Hoff1, J O'Neil.   

Abstract

In this study we assessed whether low density lipoproteins (LDL) isolated from minced aortic atherosclerotic plaques obtained at autopsy (A-LDL) shared structural and functional properties with LDL oxidized by incubation with Cu2+ for 8-18 hours at 20 degrees C (Ox-LDL). Although both A-LDL and Ox-LDL represented monomeric particles about the size of LDL, both differed from LDL in that they showed an increase in electrophoretic mobility relative to LDL, an increase in cholesterol to protein ratio, and an increase in reactivity with a monoclonal antibody that recognizes epitopes on malondialdehyde (MDA)-modified proteins. In addition, both showed an increase in fluorescence at 360 nm excitation, 430 nm emission, an increase in fragmentation of apolipoprotein B with patterns that were quite similar, and an increase in recognition by the scavenger receptor on mouse peritoneal macrophages (MPMs) based on competition of 125I-A-LDL and 125I-Ox-LDL degradation by excess acetylated LDL. In addition, inhibition of degradation by MPMs of 125I-A-LDL and 125I-Ox-LDL by excess unlabeled Ox-LDL and A-LDL were similar. When MDA was added in increasing amounts to labeled LDL and A-LDL, less MDA was required to modify A-LDL than LDl to obtain ligands that were degraded by MPMs to the same degree. Finally, both A-LDL and Ox-LDL but not LDL underwent aggregation (increased metastability) when concentrated to levels exceeding 1 mg protein/ml and showed enhanced macrophage uptake via phagocytosis (inhibition by cytochalasin D). These results demonstrate that A-LDL and Ox-LDL share properties additional to those previously reported, suggesting that oxidation may be a major mode of modification of LDL accumulating in atherosclerotic lesions. This could lead to lipid loading of macrophages induced by phagocytosis of aggregated particles, in addition to unregulated uptake via the scavenger receptor of monomeric particles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911707     DOI: 10.1161/01.atv.11.5.1209

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  15 in total

1.  Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.

Authors:  S Koskinen; C Enockson; M F Lopes-Virella; G Virella
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

Review 2.  Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases.

Authors:  Seonwook Kim; Venkateswaran Subramanian; Ahmed Abdel-Latif; Sangderk Lee
Journal:  Metab Syndr Relat Disord       Date:  2020-02-20       Impact factor: 1.894

3.  C-reactive protein induced rearrangement of phosphatidylcholine on nanoparticle mimics of lipoprotein particles.

Authors:  Marilyn R Mackiewicz; Heather L Hodges; Scott M Reed
Journal:  J Phys Chem B       Date:  2010-04-29       Impact factor: 2.991

4.  Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.

Authors:  P Holvoet; G Perez; H Bernar; E Brouwers; B Vanloo; M Rosseneu; D Collen
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 5.  LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.

Authors:  M Aviram; B Fuhrman
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 6.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

7.  Evidence for a concerted reaction between lipid hydroperoxides and polypeptides.

Authors:  J Fruebis; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 8.  Oxidation of LDL: role in atherogenesis.

Authors:  H F Hoff; J A O'Neil
Journal:  Klin Wochenschr       Date:  1991-12-15

9.  Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

Authors:  P Holvoet; G Perez; Z Zhao; E Brouwers; H Bernar; D Collen
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.

Authors:  V V Tertov; V V Kaplun; A N Orekhov
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.